Pfizer Inc (PFE)

$25.22 +0.18 (0.72%)
Market Cap 142.37B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.63
Forward PE 7.70
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 63,074,900
Avg Vol 74,806,883
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 43%
Beta 0.54
Analysts Sell
Price Target $28.23

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
LoneBroker
LoneBroker Nov. 25 at 7:04 AM
$ADMA $SOUN $NVDA $PLTR $PFE
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 25 at 4:42 AM
💎 LiquidTheta® Live Actionable Trade Asset: $PFE Contracts: $PFE December 18, 2026 $27 Calls Scale in: $1.72- $2.10 Scale out: $6.69-$11.46 Profit Potential : 180% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Stayinvest
Stayinvest Nov. 25 at 2:36 AM
$PFE watch this tomorrow very interesting 👇
0 · Reply
Stayinvest
Stayinvest Nov. 25 at 2:35 AM
$PFE https://x.com/billoreilly/status/1992785277371486241?s=10
0 · Reply
Crestpontoon
Crestpontoon Nov. 25 at 2:04 AM
$PFE
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 25 at 1:50 AM
Hedge Alert Live - Protect Your Portfolio Contract: $PFE $25.00 Put · DEC 05, 2025 Exp Entry Price: $0.29 - $0.32 Exit Price Target: $0.47 Profit Margin: +61% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
parcha
parcha Nov. 25 at 1:12 AM
$PFE To Cramer, Pfizer can act as a “bond equivalent,” noting that the pharmaceutical giant has a nearly 6.9% yield. He also suggested that the drug maker has the potential to use the businesses it’s acquired recently to build up a powerful pipeline — which could offset the numerous patent expirations the company is facing over the next few years. Cramer also said Pfizer’s hefty cash flow allows it to easily cover the dividend, adding that longer term, the company could “get through this tricky period” and see its stock break out. https://www.cnbc.com/2025/11/21/jim-cramer-three-lower-risk-stocks-high-dividends.html
0 · Reply
biolover
biolover Nov. 25 at 12:38 AM
$GUTS $NVO $PFE $VKTX Viking had FMR that screwed its SP out of lack of data understanding .. Stop this institutions nonsense and do your dd I find GUTS extreme therapy for wt loss maintenance that requires skilled MDs .. not for this time. It’s very low MC reflects that.
1 · Reply
JoeTheMiner
JoeTheMiner Nov. 25 at 12:12 AM
$GUTS has 144 institutional owners and shareholders that have filed 13D/G or 13F forms Fractyl Health, Inc. (US:GUTS) has 144 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92,869,462 shares. Largest shareholders include Nantahala Capital Management, LLC, Silverarc Capital Management, Llc, Alyeska Investment Group, L.P., Woodline Partners LP, Catalio Capital Management, LP, Rosalind Advisors, Inc., General Catalyst Group Management, Llc, Deer Management Co. LLC, HCC Manager LLC, and 683 Capital Management, LLC . $VKTX $PFE $NVO
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 24 at 11:48 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: DEC 19 2025 Buy in Price: $0.44 - $0.46 Sell Price: $0.63 Profit : +43% (Turn every $1 into $1.43) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Latest News on PFE
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Nov 21, 2025, 1:24 PM EST - 3 days ago

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 4 days ago

Pfizer Crosses Below Key Moving Average Level

$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield

Nov 20, 2025, 11:17 AM EST - 4 days ago

$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield

AMGN BMY GILD IVV MRK SPY VOO

October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs

Nov 19, 2025, 5:43 PM EST - 5 days ago

October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs

CAG CIM EPD HAFN HRL IPG KEY

Pfizer: Is This Pharma Giant Finally A Bargain

Nov 19, 2025, 3:51 PM EST - 5 days ago

Pfizer: Is This Pharma Giant Finally A Bargain

Pfizer in $41.5 million settlement with Texas over ADHD drug

Nov 19, 2025, 10:31 AM EST - 5 days ago

Pfizer in $41.5 million settlement with Texas over ADHD drug

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 6:58 AM EST - 5 days ago

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

Nov 18, 2025, 4:21 PM EST - 6 days ago

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

AZN JNJ LLY MDT MRK NVO OLMA

Global drugmakers rush to boost US presence as tariff threat looms

Nov 18, 2025, 8:25 AM EST - 6 days ago

Global drugmakers rush to boost US presence as tariff threat looms

ABBV AMGN AZN BIIB GILD GSK JNJ

US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says

Nov 17, 2025, 6:54 PM EST - 7 days ago

US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says

CVX QCOM CSCO GD

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

Nov 17, 2025, 4:05 PM EST - 7 days ago

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

INCY PPH VRTX XBI XLV

Activist Starboard sells Pfizer stake after pushing for changes

Nov 14, 2025, 6:33 PM EST - 10 days ago

Activist Starboard sells Pfizer stake after pushing for changes

Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman

Nov 14, 2025, 3:19 PM EST - 10 days ago

Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman

ABBV AZN JNJ LLY MRK NVO XLV

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Nov 14, 2025, 7:02 AM EST - 10 days ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

VTRS XRAY

Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race

Nov 13, 2025, 6:19 PM EST - 11 days ago

Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race

NVO

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

Nov 13, 2025, 5:20 PM EST - 11 days ago

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

BNTX

Pfizer CEO: RFK Jr. "clearly" was not his HHS Secretary choice

Nov 13, 2025, 2:16 PM EST - 11 days ago

Pfizer CEO: RFK Jr. "clearly" was not his HHS Secretary choice

Pfizer CEO: AI will help with medicine's next big breakthrough

Nov 13, 2025, 1:07 PM EST - 11 days ago

Pfizer CEO: AI will help with medicine's next big breakthrough

Pfizer Completes Acquisition of Metsera

Nov 13, 2025, 11:26 AM EST - 11 days ago

Pfizer Completes Acquisition of Metsera

MTSR

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

Nov 13, 2025, 11:10 AM EST - 11 days ago

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

BNTX

Metsera shareholders vote for $10 billion acquisition by Pfizer

Nov 13, 2025, 9:18 AM EST - 11 days ago

Metsera shareholders vote for $10 billion acquisition by Pfizer

MTSR

BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025, 8:17 AM EST - 11 days ago

BioNTech says collaboration with Pfizer remains unchanged

BNTX

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Nov 12, 2025, 10:00 AM EST - 12 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Johnson Fistel Investigates Fairness of Proposed Sale of Metsera

Nov 11, 2025, 1:57 PM EST - 13 days ago

Johnson Fistel Investigates Fairness of Proposed Sale of Metsera

Pfizer Inc. (PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology Transcript

Nov 11, 2025, 3:31 AM EST - 14 days ago

Pfizer Inc. (PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology Transcript

Pfizer to buy Metsera in deal worth up to $10 billion

Nov 10, 2025, 10:30 AM EST - 14 days ago

Pfizer to buy Metsera in deal worth up to $10 billion

MTSR

Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs

Nov 10, 2025, 10:21 AM EST - 14 days ago

Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs

MTSR

Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.

Nov 10, 2025, 8:05 AM EST - 14 days ago

Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.

Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Winner.

Nov 10, 2025, 7:32 AM EST - 14 days ago

Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Winner.

MTSR NVO

Dividend Income: Lanny's September 2025 Summary

Nov 10, 2025, 5:27 AM EST - 14 days ago

Dividend Income: Lanny's September 2025 Summary

O PEP PM TGT VYM VZ

U.S. Senate Makes Progress on Shutdown Deal, Novo Nordisk Loses Out to Pfizer

Nov 10, 2025, 3:45 AM EST - 15 days ago

U.S. Senate Makes Progress on Shutdown Deal, Novo Nordisk Loses Out to Pfizer

NVO

Pfizer wins $10 billion bidding war for obesity drug developer

Nov 8, 2025, 4:14 PM EST - 16 days ago

Pfizer wins $10 billion bidding war for obesity drug developer

Pfizer clinches $10 billion Metsera deal, outbidding Novo Nordisk

Nov 8, 2025, 9:54 AM EST - 16 days ago

Pfizer clinches $10 billion Metsera deal, outbidding Novo Nordisk

Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer

Nov 8, 2025, 6:38 AM EST - 16 days ago

Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer

ABBV

Pfizer has agreed to buy weight-loss drug startup Metsera in a deal that could be worth more than $10 billion, besting rival Novo Nordisk following a heated bidding war

Nov 7, 2025, 10:07 PM EST - 17 days ago

Pfizer has agreed to buy weight-loss drug startup Metsera in a deal that could be worth more than $10 billion, besting rival Novo Nordisk following a heated bidding war

MTSR

Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

Nov 7, 2025, 9:32 PM EST - 17 days ago

Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

MTSR

Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports

Nov 7, 2025, 7:59 PM EST - 17 days ago

Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports

MTSR

Pfizer: The Storm Has Passed -- Tailwinds Ahead

Nov 6, 2025, 2:00 PM EST - 18 days ago

Pfizer: The Storm Has Passed -- Tailwinds Ahead

What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?

Nov 6, 2025, 12:01 PM EST - 18 days ago

What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?

MTSR NVO

Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal

Nov 6, 2025, 11:40 AM EST - 18 days ago

Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal

MTSR

Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle

Nov 6, 2025, 8:49 AM EST - 18 days ago

Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle

MTSR

Pfizer's Slow Burn Comeback

Nov 6, 2025, 7:20 AM EST - 18 days ago

Pfizer's Slow Burn Comeback

Wall Street Breakfast Podcast: Government Shutdown Hits New Altitude

Nov 6, 2025, 6:29 AM EST - 18 days ago

Wall Street Breakfast Podcast: Government Shutdown Hits New Altitude

MTSR NVO WBD

Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman

Nov 5, 2025, 6:02 PM EST - 19 days ago

Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman

MTSR

Pfizer Responds to Delaware Chancery Court Ruling

Nov 5, 2025, 5:08 PM EST - 19 days ago

Pfizer Responds to Delaware Chancery Court Ruling

Pfizer preparing to raise its bid for Metsera, WSJ reports

Nov 5, 2025, 5:02 PM EST - 19 days ago

Pfizer preparing to raise its bid for Metsera, WSJ reports

MTSR

Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that also involves Novo Nordisk

Nov 5, 2025, 4:52 PM EST - 19 days ago

Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that also involves Novo Nordisk

MTSR NVO

Delaware judge says she will not block Metsera from ending Pfizer deal

Nov 5, 2025, 4:20 PM EST - 19 days ago

Delaware judge says she will not block Metsera from ending Pfizer deal

MTSR

Pfizer says it removed some conditions from its Metsera bid

Nov 5, 2025, 2:19 PM EST - 19 days ago

Pfizer says it removed some conditions from its Metsera bid

MTSR

Pfizer: Market Still Pricing It At Crisis Valuations

Nov 5, 2025, 11:30 AM EST - 19 days ago

Pfizer: Market Still Pricing It At Crisis Valuations

LoneBroker
LoneBroker Nov. 25 at 7:04 AM
$ADMA $SOUN $NVDA $PLTR $PFE
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 25 at 4:42 AM
💎 LiquidTheta® Live Actionable Trade Asset: $PFE Contracts: $PFE December 18, 2026 $27 Calls Scale in: $1.72- $2.10 Scale out: $6.69-$11.46 Profit Potential : 180% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Stayinvest
Stayinvest Nov. 25 at 2:36 AM
$PFE watch this tomorrow very interesting 👇
0 · Reply
Stayinvest
Stayinvest Nov. 25 at 2:35 AM
$PFE https://x.com/billoreilly/status/1992785277371486241?s=10
0 · Reply
Crestpontoon
Crestpontoon Nov. 25 at 2:04 AM
$PFE
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 25 at 1:50 AM
Hedge Alert Live - Protect Your Portfolio Contract: $PFE $25.00 Put · DEC 05, 2025 Exp Entry Price: $0.29 - $0.32 Exit Price Target: $0.47 Profit Margin: +61% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
parcha
parcha Nov. 25 at 1:12 AM
$PFE To Cramer, Pfizer can act as a “bond equivalent,” noting that the pharmaceutical giant has a nearly 6.9% yield. He also suggested that the drug maker has the potential to use the businesses it’s acquired recently to build up a powerful pipeline — which could offset the numerous patent expirations the company is facing over the next few years. Cramer also said Pfizer’s hefty cash flow allows it to easily cover the dividend, adding that longer term, the company could “get through this tricky period” and see its stock break out. https://www.cnbc.com/2025/11/21/jim-cramer-three-lower-risk-stocks-high-dividends.html
0 · Reply
biolover
biolover Nov. 25 at 12:38 AM
$GUTS $NVO $PFE $VKTX Viking had FMR that screwed its SP out of lack of data understanding .. Stop this institutions nonsense and do your dd I find GUTS extreme therapy for wt loss maintenance that requires skilled MDs .. not for this time. It’s very low MC reflects that.
1 · Reply
JoeTheMiner
JoeTheMiner Nov. 25 at 12:12 AM
$GUTS has 144 institutional owners and shareholders that have filed 13D/G or 13F forms Fractyl Health, Inc. (US:GUTS) has 144 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92,869,462 shares. Largest shareholders include Nantahala Capital Management, LLC, Silverarc Capital Management, Llc, Alyeska Investment Group, L.P., Woodline Partners LP, Catalio Capital Management, LP, Rosalind Advisors, Inc., General Catalyst Group Management, Llc, Deer Management Co. LLC, HCC Manager LLC, and 683 Capital Management, LLC . $VKTX $PFE $NVO
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 24 at 11:48 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: DEC 19 2025 Buy in Price: $0.44 - $0.46 Sell Price: $0.63 Profit : +43% (Turn every $1 into $1.43) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Iightning
Iightning Nov. 24 at 11:10 PM
1ightning® Options Trade Alert (Actionable) | Buy $PFE Dec 5 $26 Call | Enter: $0.33 Exit: $0.59 | Profit: 79.83% ROI | https://1ightning.com
0 · Reply
SeriouslyWhy
SeriouslyWhy Nov. 24 at 10:44 PM
$PFE just another day at Pfizer same shit different day at least they pay me to hold this shit
2 · Reply
LLMAgent
LLMAgent Nov. 24 at 10:02 PM
$PFE If you’re new here - Remember, this company is toast. Very Bad fundamentals, masked by green ER reports. Baggies here will try to trap you with crap vague statements like : paid dividend for xxxx quarters, 7% dividend, very cheap, manipulated by MMs so that institutes can accumulate, oncology will be blockbuster blah blah. Use your head to do a balance sheet health analysis, pipeline analysis, and ignore the baggies. You’ll realize the company has NOTHING. The few hits it had will run against the patent expiry wall in 2026. Oncology is heavily crowded. No obesity play till 2028, optimistically. All of their cash flow is going into paying the dividend. Huge debt, made even higher by the Metsera acquisition. Then slowly back away from this radioactive pile of trash before the baggie zombies try to lure you into becoming one of them.
1 · Reply
SeriouslyWhy
SeriouslyWhy Nov. 24 at 9:32 PM
$PFE end of day drop as usual
0 · Reply
Jblack500
Jblack500 Nov. 24 at 9:08 PM
$BBIO $GILD $ABBV $PFE a 7 handle...she's come a long way
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Nov. 24 at 8:51 PM
$PFE, pfizzing out as usual
0 · Reply
Ben_Dover_U
Ben_Dover_U Nov. 24 at 8:46 PM
$BNTX $MRNA $PFE YEAH She did!! multiple boosters jabs as well... Remember, her side of the family is heavily invested in big Pharma, and is on the payroll as well. They do nothing But trash RFK Jr. but, he's not the one suffering from immune system destruction via the MRNA gene therapies.
0 · Reply
JoeTheMiner
JoeTheMiner Nov. 24 at 6:02 PM
$GUTS chart breaking up ? Are you paying attention? $NVO $NVS $PFE
0 · Reply
HoodyHaz
HoodyHaz Nov. 24 at 5:52 PM
$ALT $PFE $NVO Novo & pfizer had bidding war to $10 billion for an inferior asset.. Compared to Pemvidutide… Remember the New Super Bowl ad for weight loss drug.. coming soon!!
1 · Reply
HoodyHaz
HoodyHaz Nov. 24 at 5:46 PM
$ALT We have a fully de risked obesity asset… ”Best In Class” 10 days ago $PFE paid $10 billion for an inferior molecule 25 times our market cap
0 · Reply
taxplanr
taxplanr Nov. 24 at 5:40 PM
$BNTX $MRNA $PFE
2 · Reply
taxplanr
taxplanr Nov. 24 at 5:40 PM
$BNTX $MRNA $PFE C19 bioweapons linked to MS Lupus Diabetes Rheumatoid Arthritis Graves' Disease and Hashinoto's Thyroiditis https://www.thefocalpoints.com/p/breaking-study-covid-19-vaccines-f6c?r=14jb45&utm_campaign=post&utm_medium=web&showWelcomeOnShare=false
0 · Reply